Clinical Trials Logo
  1. Home
  2. Skin Toxicity
  3. NCT04650256

Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences

Skin Toxicity Clinical Trial

Official title:
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences

Clinical Trial Summary

The purpose of this research is to study a Chinese herbal Complementary and Alternative Medicine (CAM) product for the temporary relief of pain and itching after radiotherapy (RT). This is an over-the-counter product with 1% menthol as an active ingredient.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04650256
Study type Interventional
Source University of Miami
Contact Jennifer J Hu, PhD
Phone 3052437796
Email jhu@med.miami.edu
Status Recruiting
Phase N/A
Start date July 1, 2021
Completion date December 31, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04929834 - Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities N/A
Completed NCT04929847 - Novel Skin Care for Chemotherapy- Related Dermatologic Toxicities N/A
Not yet recruiting NCT03606954 - Potency of Topical Corticosteroids in Combination Preparations Phase 4
Completed NCT01976481 - Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27 N/A
Completed NCT03448731 - Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) Phase 2
Recruiting NCT05109858 - Skin Toxicity by Oncological Therapies
Completed NCT00871429 - Skin Care for Cancer Patients: A Product Satisfaction Survey N/A
Recruiting NCT04469075 - Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields Phase 2
Terminated NCT01317433 - Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer N/A
Active, not recruiting NCT03167268 - Panitumumab Skin Toxicity Prevention Trial Phase 2
Recruiting NCT06118047 - Crisaborole Ointment for Skin Toxicity Induced by Cetuximab Phase 2